OraSure Seeks Panel Feedback On Marketing Of Home-Use HIV Test
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies will seek guidance from FDA's Blood Product's Advisory Committee on making its OraQuick Advance oral HIV test available over the counter for use in the home
You may also be interested in...
OraSure Studying “Site-Specific Factors” Behind Flawed HIV Test Results
OraSure is conducting an investigation of its OraQuick Advance rapid oral HIV test due to concerns about the test's reliability, the company said Dec. 20
OraSure Studying “Site-Specific Factors” Behind Flawed HIV Test Results
OraSure is conducting an investigation of its OraQuick Advance rapid oral HIV test due to concerns about the test's reliability, the company said Dec. 20
FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests
Over-the-counter (OTC) HIV test kits would answer an unmet need, but clinical trials and product labeling must be carefully crafted to ensure that benefits outweigh the risks, according to FDA's Blood Products Advisory Committee